Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Bipolar Postpartum Depression
NCT02726659Phase 3Terminated
- Start
- May 2016
- Primary completion
- Jan 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar disorder (BD) comparing Celecoxib Arm with Placebo Arm (2 arms). Primary endpoint: Hamilton Rating Scale for Depression at 6 weeks. Started May 2016; status: terminated.
02
Drugs
celecoxib
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02726659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726659.